Skip to main content
Premium Trial:

Request an Annual Quote

Wendell Jones, Samraat Raha, Jim Slater, Mark Chandler, Walter Loewenbaum, Thomas Erickson, Mickey Urdea, Elena Grigorenko


Wendell Jones has joined Expression Analysis of Research Triangle Park, N.C., as a senior research statistician. Jones, who holds a PhD in mathematical sciences from Clemson University, previously worked for IBM as a senior software reliability engineer and as a manager of research and technology at Nortel Networks.

Samraat Raha has become chief business officer of Madison, Wis.-based EraGen. He joins the company from Incyte Genomics, where he was vice president of discovery services, including microarrays and bioreagents. Raha received a BA in molecular and cell biology from the University of California at Berkeley.

Jim Slater, executive chairman of investment company BioProjects International, has joined ViaLogy’s board of directors. BioProject International has been the lead investor of ViaLogy’s recent series A round. ViaLogy, a portfolio company of Viaspace Technologies, is developing technology to increase the detection sensitivity of DNA microarrays and other platforms.

Mark Chandler is planning to resign as president and CEO of Luminex in order to become chairman and CEO of a spinout the company is hoping to form of its Rules-Based Medicine unit (see story on page 1). While Chandler would remain a director of Luminex, Walter Loewenbaum would succeed him as chairman of the board of directors, and Thomas Erickson would join Luminex as interim president and CEO.

Mickey Urdea has been appointed to the board of directors of Quantum Dot, based in Hayward, Calif. Urdea is a founder of Chiron and a former senior vice president of nucleic acid diagnostics at Bayer. At Chiron, he developed branched DNA hybridization assays. After leaving Bayer, Urdea, who holds a PhD in biochemistry from Washington State University, became a biotechnology consultant for sev-eral firms.

Elena Grigorenko has joined the advisory board of NuGEN of San Carlos, Calif. She has been a researcher at Millennium Pharmaceuticals since 2000, where she has been responsible for projects that include microarray platform evaluations and RNA labeling improvements. Prior to that, Grigorenko was an instructor and assistant professor at the Wake Forest University school of medicine where she directed the molecular biology/microarray core facility. She holds a PhD in biochemistry from the Institute of Biological Physics of the Russian Academy of Sciences.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.